News

Jeudi 23 mai 2024 – 18h30 Café Brasserie Beau-Soleil Le Programme Fistula Group de la Fondation Genevoise pour la Formation et la Recherche Médicales (GFMER) et Genolier Foundation vous convient au vernissage du livre “Revivre”. Conférence et cocktail dînatoire 📅 Date : 23 mai 2024 📍 Lieu : Café Brasserie Beau-Soleil, Clinique Générale-Beaulieu, 1206 Genève…

The Swiss International Prostate Center is introducing two cutting-edge tests for the diagnosis of prostate cancer. The first one, Stockholm3, is a blood test used to detect – or to rule out – early stage prostate cancer. It is of particular relevance for men with elevated PSA levels or abnormal MRI findings in whom a…

Dear Colleague, On the occasion of the 20th anniversary of Imagerive and the 10th anniversary of Uroimage, we are pleased to invite you to participate in our 9th in-person symposium on prostate cancer on October 31, 2023, from 9:00 a.m. to 6:00 p.m. Inscription Voir le programme

Cher(e) Collègue, A l’occasion des 20 ans d’Imagerive et des 10 ans d’Uroimage, nous avons le plaisir de vous inviter à participer à notre 9ème symposium en présentiel autour du cancer de la prostate le 31 octobre 2023, de 9h00 à 18h00. Un homme sur huit développera un cancer de la prostate au cours de…

Dr. Martins and her team (formed by 4 radiologists), read an average of 35 prostate MRIs a week, which brings the total average to about 1500 exams a year. A number that is rapidly increasing due to the change in guidelines for PCa diagnosis published by the EAU (European Association of Urology) and the ACR…

First day of the “fistula mission” in Benin and first capsule of Dr. Rochat. This first step is marked by the visit of the Fistula Group team to the urology department of Prof. Josue Avakoudjo, and the meeting with Mathieu Ogoudjobi, fistula focal point at the national level, as well as an exchange with the…

This year, Clinique Générale-Beaulieu celebrates 20 years of robotic surgery. Back on this success story with the story of a robot, the da Vinci in the field of urology. In March 1999, two urological surgeons, Drs Richard Gaston from Bordeaux and Charles-Henry Rochat from Geneva, collaborated to carry out at the Clinique Générale-Beaulieu the first…

One in eight men will develop prostate cancer in their lifetime. It is the most common cancer in men, with more than 5,000 new cases being detected in Switzerland each year. Although relatively common, prostate cancer is not inevitable. It is even the cancer that is best cured, in particular thanks to diagnostic methods and…

Tuesday 20 September at 5.30 p.m. – Société Nautique de Genève Treatment of benign prostatic hyperplasia. Big success